START appoints Dr Frank Smith as president of its XenoSTART preclinical research business unit: San Antonio, Texas Friday, ...

A milestone for Indian medtech, NIT Rourkela-developed StopBleed receives regulatory approval: Our Bureau, Chennai Friday, ...

IDEAYA Biosciences begins patient enrolment in phase 1 trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC: South San Francisco, California Friday, February 27, 2026 ...

US FDA accepts Vanda Pharmaceuticals’ BLA for imsidolimab to treat Generalized Pustular Psoriasis: Washington Friday, February 27, 2026, 17:00 Hrs [IST] Vanda Pharmaceuticals In ...

China NMPA accepts for priority review GSK’s NDA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Friday, February 27, 2026, 14: ...

Mevion Medical Systems’ MEVION S250-FIT Proton Therapy System receives European Union CE marking: Littleton, Massachusetts Friday, February 27, 2026, 16:00 Hrs [IST] Mevion Medi ...

Lupin Ranks No. 1 globally in pharma; Tops all sectors in India in S&P ESG Assessment 2025: Our Bureau, Mumbai Friday, February 27, 2026, 11:30 Hrs [IST] Global pharma major Lupin ...

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that the full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc ...

Asahi Kasei Pharma strengthens preclinical pipeline through exclusive global license pact with Alchemedicine for novel lead compounds: Tokyo Friday, February 27, 2026, 11:00 Hrs [ ...

Our Bureau, Mumbai Friday, February 27, 2026, 13:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has ...

Our Bureau, Chennai Friday, February 27, 2026, 12:15 Hrs [IST] ...

GSK’s bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B: London, UK Friday, February 27, 2026, 09:00 Hrs [IST] ...